BLR&D Research Career Scientist Award Application

BLR

基本信息

项目摘要

Dr. Lau is an internationally recognized investigator in the Y chromosome biology and an established expert in molecular genetics and transgenic mouse modeling of human diseases. He has established various molecular tools in his laboratory, installed advanced next generation sequencing equipment and bioinformatics in the Molecular Core, and served as consultant for PIs interested in such advanced technologies at the SFVA. Currently, he has several established and pilot projects. First project focuses on the roles of the Y-located proto-oncogene TSPY in liver and prostate cancers. TSPY is the gene for the gonadoblastoma locus on the Y chromosome (GBY), the only oncogenic locus on this male-specific chromosome. Normally, it functions as a male germ stem cell factor, but as an oncogene when ectopically expressed in somatic cells, such as prostate epithelial cells and hepatocytes. It stimulates cell proliferation and cyclin B-CDK1 kinase activities. TSPY forms a positive feedback loop with male sex hormone receptor AR and constitutively active variant AR-V7, thereby amplifying their respective oncogenic actions. Research centers on exploring the correlation between TSPY, AR/AR-V7 expression and clinical features and outcomes in liver and prostate cancers; and on studying experimentally the contributions of TSPY and AR/AR-V7 in oncogenesis in liver and prostate cancer. Validation of the roles of TSPY in AR/AR-V7 in the male-dominance in liver cancer could offer immediate translational applications of effective anti-AR/AR-V7 drugs already developed for prostate cancer to the treatment of liver cancer. The second project focuses on the X-located homologue of TSPY, TSPX on human oncogenesis. Due to evolutionary divergence, TSPX possesses contrasting properties, i.e. retards cell proliferation, inhibits cyclin B-CDK1 and AR/AR-V7 transactivation activities, and behaves as a tumor suppressor in various cancers, including lung, liver and prostate cancers. Studies are designed to identify their respective oncogenic and tumor suppressor domains, and signaling pathways in oncogenesis. The third project focuses on the genes on the male-specific region of the Y chromosome (MSY) in sex differences in various physiology and diseases. The current emphasis is on the sex-determining gene SRY, which is essential for sex determination, but not for the development of non-gonadal tissues. Dr. Lau has established an efficient transgene activation system and demonstrated that aberrant expression of a human SRY induces various abnormalities in transgenic mice, including retardation in neurogenesis and postnatal lung development, nonalcoholic fatty liver disease and myocardial infarction. Studies are being conducted to characterize the mechanisms of diseases, mediated by aberrant SRY expression in the respective tissues. The fourth project focuses on the recently observed link between mosaic loss of the Y chromosome (mLOY) in the peripheral blood and increased risks and mortality in elderly men. In collaborations with Health Research scientists at SFVA, Dr. Lau plans to explore the possibility of using mLOY as screening tool for cancers and cardiovascular and neurodegenerative diseases among the Veterans, such as the databases of the Million Veteran Program (MVP). He hypothesizes that mLOY results in dosage unbalance of the highly conserved X-Y homologous genes, such as the histone lysine demethylases SMCY and UTY, resulting in deficiency in immunosurveillance and predisposition of affected tissues to disease development. He will use transgenic mouse models to evaluate such genetic predisposition, characterize them with advanced genomics and bioinformatics techniques and correlate the results with clinical observations. Dr. Lau is a key and contributing member of the SFVA. He has developed a continuously funded research program using advanced molecular genetics, genomics, bioinformatics and transgenic mouse approaches. His research has provided useful biomarkers for precise diagnosis, prognosis, and targets for therapeutics; and the scientific supports for sex differences and disease mechanisms, essential in establishing the precision medicine for the efficient and effective deliveries of healthcare for our Veterans.
刘博士是国际公认的Y染色体生物学研究者,并建立了

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YUN-FAI CHRIS LAU其他文献

YUN-FAI CHRIS LAU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YUN-FAI CHRIS LAU', 18)}}的其他基金

BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10515304
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Molecular Mechanisms of a Male-Specific Positive Feedback Loop in Liver Cancer
肝癌男性特异性正反馈环的分子机制
  • 批准号:
    10202474
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
ShEEP Request for Single-Cell Next-Generation Sequencing Library Preparation System
ShEEP 请求单细胞下一代测序文库制备系统
  • 批准号:
    9906732
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10047239
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Role of the Y-Located TSPY Gene in Human Oncogenesis
Y 定位的 TSPY 基因在人类肿瘤发生中的作用
  • 批准号:
    8196347
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Role of the Y-Located TSPY Gene in Human Oncogenesis
Y 定位的 TSPY 基因在人类肿瘤发生中的作用
  • 批准号:
    8391614
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Sex Chromosomes and Gender Disparity in HBV-Related Hepatocellular Carcinoma
HBV 相关肝细胞癌中的性染色体和性别差异
  • 批准号:
    8116508
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Role of the Y-Located TSPY Gene in Human Oncogenesis
Y 定位的 TSPY 基因在人类肿瘤发生中的作用
  • 批准号:
    7931856
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Role of the Y-Located TSPY Gene in Human Oncogenesis
Y 定位的 TSPY 基因在人类肿瘤发生中的作用
  • 批准号:
    8597395
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
Sex Chromosomes and Gender Disparity in HBV-Related Hepatocellular Carcinoma
HBV 相关肝细胞癌中的性染色体和性别差异
  • 批准号:
    7977982
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了